If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and healthcare industries and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts for all the Big Pharmas, forecasting, int ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts for all the Big Pharmas, forecasting, int ...

The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts for all the Big Pharmas, forecasting, integrated financial statements, discounted cash flow analysis and market by market analysis. Learn moreEdmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing g ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

This article is published by Terry Chrisomalis, who runs the Biotech Analysis Central pharmaceutical service on Seeking Alpha Marketplace. If you like what you read here and would like to subscribe to, I'm currently offering a two-week free trial period for subscribers to take advantage of. My service offers a deep-dive analysis of many pharmaceutical companies. The Biotech Analysis Central SA marketplace is $49 per month, but for those who sign up for the yearly plan will be able to take advantage of a 33. ...

文章核心观点 - 文章作者Terry Chrisomalis运营Seeking Alpha平台上的Biotech Analysis Central医药服务 提供生物制药公司深度分析及投资研究服务[1] - 该服务包含600多篇生物技术投资文章库 以及10多只中小盘股票组成的模型投资组合 配备实时聊天和各类分析报告[2] 服务订阅模式 - 月度订阅费为49美元 年度订阅可享受33.50%折扣 年费价格为399美元[1] - 目前为新订阅用户提供两周免费试用期[1] 作者资质声明 - 作者声明未持有任何提及公司的股票、期权或衍生品头寸 且未来72小时内无建仓计划[3] - 文章内容为作者个人观点 未获得除Seeking Alpha外任何形式的报酬[3] - 作者与提及股票的公司不存在业务关系[3] 平台性质说明 - Seeking Alpha并非持牌证券交易商、经纪商或美国投资顾问/投行机构[4] - 平台分析师包含专业投资者和个体投资者 部分未获得机构或监管机构认证许可[4]

文章核心观点 - 该文章是Biotech Analysis Central医药服务在Seeking Alpha平台发布的订阅推广内容 提供生物制药公司的深度分析服务 订阅费用为每月49美元或每年399美元(享受33.5%折扣) [1] - 服务包含600多篇生物技术投资文章库 10余只中小盘股票的投资组合深度分析 实时聊天功能以及各类分析新闻报道 [2] 服务内容 - 提供医药公司的深度分析研究服务 [1] - 包含600多篇生物技术投资文章库 [2] - 建立10余只中小盘股票模型投资组合并提供深度分析 [2] - 提供实时聊天功能和各类分析新闻报道 [2] 订阅方案 - 月度订阅费用为49美元 [1] - 年度订阅费用为399美元 相比月度方案享受33.5%的价格折扣 [1] - 目前提供两周免费试用期 [1]

文章核心观点 - 该文章是Biotech Analysis Central医药服务作者Terry Chrisomalis发布的订阅推广内容 提供为期两周的免费试用期 订阅服务月费49美元 年度计划可享受335%折扣价即399美元每年 [1] - 该投资小组拥有超过600篇生物技术投资文章库 包含10余只中小盘股票的组合深度分析 提供实时聊天和各类分析新闻报道 [2] 作者及服务内容 - 作者运营Biotech Analysis Central医药数据分析服务 专注于对多家医药公司进行深度剖析 [1] - 服务内容包括实时讨论功能 协助医疗保健领域投资者做出知情决策 [2] 免责声明相关 - 作者声明未持有任何提及公司的股票、期权或类似衍生品头寸 且未来72小时内无相关头寸计划 [3] - 寻求阿尔法平台披露声明：过往业绩不预示未来结果 不提供投资建议 分析师为第三方作者 包含未获机构或监管机构许可认证的专业投资者和个人投资者 [4]

服务内容 - 提供生物制药公司的深度分析服务，涵盖600多篇生物科技投资文章 [2] - 服务包含一个由10多只中小盘股票组成的模型投资组合，每只股票均有详细分析 [2] - 提供实时聊天功能以及各类分析和新闻报告，帮助医疗保健投资者做出决策 [2] 订阅计划 - 月度订阅价格为49美元，年度订阅可享受33.50%的折扣，价格为399美元 [1] - 目前提供两周免费试用期供潜在订阅者体验 [1]